Thiolated Oligonucleotide Synthesis Without Capping Step
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The current solid-phase synthesis of thiolated oligonucleotides requires a capping step to prevent unreacted 5'-hydroxyl groups from participating in subsequent coupling reactions, increasing the number of steps and reagents needed, which can lead to inefficiencies and impurities.
Innovation Solution
A process that eliminates the capping step by using byproducts from the sulfurization step to cap unreacted 5'-hydroxyl groups, allowing for a three-reaction cycle of detritylation, coupling, and sulfurization, reducing the need for additional capping reagents and simplifying the synthesis process.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If a capping step is added to block unreacted 5'-hydroxyl groups, then the purity of the oligonucleotide product is improved, but the number of synthesis steps and reagents increases
Solution Approach 1:
The patent combines the capping function with the sulfurization step by using the sulfurization byproduct (thiol-containing compound) to cap unreacted 5'-hydroxyl groups. This merging of functions eliminates the need for a separate capping step, reducing the total number of synthesis steps while maintaining product purity.
Solution Approach 2:
The patent converts the harmful byproduct of sulfurization (which was previously considered waste) into a beneficial capping agent. The thiol-containing byproduct naturally caps unreacted 5'-hydroxyl groups, transforming a potential source of impurity into a useful functional component that prevents further unwanted reactions.
2Manufacturing precision
If a capping step is added to block unreacted 5'-hydroxyl groups, then the purity of the oligonucleotide product is improved, but the time and reagents required for synthesis increase
Solution Approach 1:
The capping and sulfurization steps are merged into a single operational sequence. The sulfurization reagent is applied first, followed immediately by the capping reagent in the same reaction vessel without intermediate processing, thereby eliminating the time required for a separate capping step while maintaining product purity.
Solution Approach 2:
The patent maintains continuous useful action by performing capping immediately after sulfurization without removing the sulfurization byproduct. The byproduct serves as the capping agent in situ, eliminating idle time and continuous processing steps, thereby reducing total synthesis time while ensuring complete capping of unreacted hydroxyl groups.
3Manufacturing precision
If conventional capping reagents like acetic anhydride are used, then unreacted 5'-hydroxyl groups are effectively blocked, but new impurities may be introduced
Solution Approach 1:
The patent converts the sulfurization byproduct, which contains thiol groups, into a beneficial capping agent. This endogenous capping agent is inherently compatible with the oligonucleotide structure and does not introduce extraneous impurities, unlike conventional capping reagents such as acetic anhydride that leave acetyl groups on the molecule.
Solution Approach 2:
The patent changes the chemical parameter of the capping agent from exogenous (acetic anhydride) to endogenous (sulfurization byproduct). This parameter change ensures that the capping group is chemically compatible with the oligonucleotide and does not introduce new impurities, while still effectively blocking unreacted 5'-hydroxyl groups.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach reduces the number of steps and reagents required, increases synthesis efficiency, and improves the purity of thiolated oligonucleotides by effectively capping unreacted groups without introducing new impurities, particularly for fully thiolated oligonucleotides, and can be adapted for partially thiolated oligonucleotides with minimal additional capping steps.
Implementation Method 1
the byproducts generated during the sulfurization step can be used to cap the unreacted 5'-hydroxy groups. These byproducts or in certain cases, the sulfurization agent itself, for example PADS, may be recirculated across the solid support to cap the 5'-hydroxy groups that failed to couple with the phosphoramidite.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The invention herein describes a synthetic method for preparing thiolated oligonucleotides without needing a capping step, as the sulfurization agent caps the unreacted 5'-OH groups.